The global hepatitis virus testing market size was valued at USD 2.9 billion in 2021 and is poised to grow at a significant CAGR of 4.8% during the forecast period 2022-28. The hepatitis C virus causes hepatitis C, which is a viral ailment (HCV). Hepatitis C is a blood-borne virus that causes liver damage and acute and chronic hepatitis. Infection can spread from an infected woman to her baby through injectable drug usage, transmission of unscreened blood products, hazardous injection techniques, and sexual contact. Anti-HCV antibodies can be used to diagnose HCV infection, and a serological test can be used to confirm the viral infection. In the case of positive anti-HCV antibody test results, a nucleic acid analysis for HCV ribonucleic acid (RNA) is conducted to confirm chronic infection.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-hepatitis-virus-testing-market/       

Hepatitis diagnostic tests are in high demand around the world at the moment. A variety of factors are now catalysing this market, including the expanding global incidence of hepatitis, the growing amount of blood transfusions as well as donations, technical improvements and the benefits afforded by PoC (Point of Care) tests, and rising awareness levels. The move from traditional testing methods to molecular diagnostics has been a prominent trend in this sector. As a result, the accuracy of the results has improved, and the total time necessary to obtain them has decreased. The World Health Organization (WHO) advises blood testing to screen patients who are at an elevated risk of HCV infection and to lower the risk of HCV exposure in health care settings because there is no vaccination for HCV infection. In most countries, screening pregnant women for HCV is considered standard of care and a cost-effective technique for lowering the risk of transmission to the baby.

The global hepatitis virus testing market segmentation:
1) By Technique: Probe Amplification, Target Amplification, Signal Amplification.
2) By Application: Cancer, Infectious Diseases, Genetics, Personalized Medicine.
3) By End Users: Hospitals, Diagnostic Centers, Research organizations, Others.  

Request sample report at  https://precisionbusinessinsights.com/request-sample?product_id=36302                                                                      

In the hepatitis virus testing market, Asia Pacific was the most dominating region, and it is projected to continue to be so over the projection period. In 2020, Asia Pacific and the Middle East and Africa had a market share of approximately of more than 65 percent. The hyper-endemicity of hepatitis E in Asia Pacific countries like India, Nepal, Bhutan, Pakistan, Vietnam, Thailand, Bangladesh, Kazakhstan, and Burma, as well as Africa countries like Uganda, Kenya, Morocco, and Nigeria, contribute to these regions' high revenue share in the hepatitis virus testing market.

The global hepatitis virus testing market key players Hoffmann-La Roche AG (Switzerland) Beckman Coulter, Inc. (U.S.) Becton, Dickinson and Company (U.S.) Abbott Laboratories, Inc. (U.S.) bioMérieux (France) Siemens Healthineers (Germany) Novartis AG (Switzerland) MedMira, Inc.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747